| Schedule of Accounts Receivable |
Accounts receivable at September 30, 2019 (unaudited)
and December 31, 2018 consisted of the following:
| |
|
September 30, |
|
|
December 31, |
|
| |
|
2019 |
|
|
2018 |
|
| Accounts receivable - Clinical Laboratory Operations |
|
$ |
41,750 |
|
|
$ |
622,009 |
|
| Accounts receivable - Hospital Operations |
|
|
45,804,056 |
|
|
|
31,607,644 |
|
| Accounts receivable - Other |
|
|
(52,296 |
) |
|
|
- |
|
| Total accounts receivable |
|
|
45,793,510 |
|
|
|
32,229,653 |
|
| Less: |
|
|
|
|
|
|
|
|
| Amount purchased by factors |
|
|
(1,572,000 |
) |
|
|
- |
|
| Allowance for discounts - Clinical Laboratory Operations |
|
|
(26,182 |
) |
|
|
(573,584 |
) |
| Allowance for discounts - Hospital Operations |
|
|
(36,298,972 |
) |
|
|
(25,066,799 |
) |
| Allowance for bad debts |
|
|
(2,787,894 |
) |
|
|
(2,777,521 |
) |
| Accounts receivable, net |
|
$ |
5,108,462 |
|
|
$ |
3,811,749 |
|
|